Matthijs van Luin
- Virology top 10%
- HIV Research and Treatment 5
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 5
-
- Pharmacological Effects and Toxicity Studies 3
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
-
- Acute Lymphoblastic Leukemia research 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- HIV-related health complications and treatments 3
- Co-authors
- David M. BurgerPaul F. M. KuksClemens RichterFerdinand W.N.M. WitMarc van der ValkC.P.W.G.M. Verwey-van WissenBas SchouwenbergFrank de Wolf
- Journals
- AIDS (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Clinical Pharmacokinetics (2 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Matthijs van Luin
27 papers receiving 257 citations
Peers
Comparison fields: 5 of 62
- Virology 57
- Infectious Diseases 136
- Pediatrics, Perinatology and Child Health 73
- Hepatology 24
- Transplantation 8
Countries citing papers authored by Matthijs van Luin
This map shows the geographic impact of Matthijs van Luin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthijs van Luin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthijs van Luin more than expected).
Fields of papers citing papers by Matthijs van Luin
This network shows the impact of papers produced by Matthijs van Luin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthijs van Luin. The network helps show where Matthijs van Luin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthijs van Luin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 9 | |
| 12 | 2019 | 29 | |
| 13 | 2019 | 4 | |
| 14 | 2010 | 12 | |
| 15 | 2010 | 14 | |
| 16 | 2010 | 6 | |
| 17 | 2009 | 20 | |
| 18 | 2009 | 26 | |
| 19 | 2008 | 21 | |
| 20 | [Acute caffeine intoxication after intake of 'herbal energy capsules']. | 2008 | 2 |
About Matthijs van Luin
Matthijs van Luin is a scholar working on Virology, Infectious Diseases and Transplantation, having authored 27 papers that have together received 260 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and HIV-related health complications and treatments (3 papers). The work is most often cited by research in Virology (57 citations), Infectious Diseases (136 citations) and Pediatrics, Perinatology and Child Health (73 citations). Matthijs van Luin has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include David M. Burger, Paul F. M. Kuks, Clemens Richter, Ferdinand W.N.M. Wit, Marc van der Valk, C.P.W.G.M. Verwey-van Wissen, Bas Schouwenberg, Frank de Wolf, Angela Colbers and Jan M. Prins. Their work appears in journals such as AIDS, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.